N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(benzylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(butan-2-ylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(3-fluoroanilino)propanamide
C77H89FN12O3S6 — CID 158059465
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(benzylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(butan-2-ylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(3-fluoroanilino)propanamide
N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(benzylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(butan-2-ylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(3-fluoroanilino)propanamide (PubChem CID 158059465) has the molecular formula C77H89FN12O3S6 and a molecular weight of 1442.04 g/mol. Its IUPAC name is N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(benzylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(butan-2-ylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(3-fluoroanilino)propanamide.
Molecular Properties
| Compound Name | N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(benzylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(butan-2-ylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(3-fluoroanilino)propanamide |
|---|---|
| PubChem CID | 158059465 |
| Molecular Formula | C77H89FN12O3S6 |
| Molecular Weight | 1442.04 g/mol |
| Exact Mass | 1440.55 |
| IUPAC Name | N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(benzylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(butan-2-ylamino)propanamide;N-[3-(1,3-benzothiazol-2-yl)-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridin-2-yl]-3-(3-fluoroanilino)propanamide |
| SMILES | CC(C)N1CCc2c(sc(NC(=O)CCNCc3ccccc3)c2-c2nc3ccccc3s2)C1.CC(C)N1CCc2c(sc(NC(=O)CCNc3cccc(F)c3)c2-c2nc3ccccc3s2)C1.CCC(C)NCCC(=O)Nc1sc2c(c1-c1nc3ccccc3s1)CCN(C(C)C)C2 |
| InChI | InChI=1S/C27H30N4OS2.C26H27FN4OS2.C24H32N4OS2/c1-18(2)31-15-13-20-23(17-31)34-27(25(20)26-29-21-10-6-7-11-22(21)33-26)30-24(32)12-14-28-16-19-8-4-3-5-9-19;1-16(2)31-13-11-19-22(15-31)34-26(24(19)25-29-20-8-3-4-9-21(20)33-25)30-23(32)10-12-28-18-7-5-6-17(27)14-18;1-5-16(4)25-12-10-21(29)27-24-22(23-26-18-8-6-7-9-19(18)30-23)17-11-13-28(15(2)3)14-20(17)31-24/h3-11,18,28H,12-17H2,1-2H3,(H,30,32);3-9,14,16,28H,10-13,15H2,1-2H3,(H,30,32);6-9,15-16,25H,5,10-14H2,1-4H3,(H,27,29) |
| InChIKey | FKMBEQAPERUFCA-UHFFFAOYSA-N |
| XLogP | 17.79 |
| TPSA | 171.78 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 99 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1442.04 |
| LogP ≤ 5 | 17.79 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158059465 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.